2013
DOI: 10.1021/ci400421e
|View full text |Cite
|
Sign up to set email alerts
|

Structurally Conserved Binding Sites of Hemagglutinin as Targets for Influenza Drug and Vaccine Development

Abstract: ProBiS is a new method to identify the binding site of protein through local structural alignment against the nonredundant Protein Data Bank (PDB), which may result in unique findings compared to the energy-based, geometry-based, and sequence-based predictors. In this work, binding sites of Hemagglutinin (HA), which is an important target for drugs and vaccines in influenza treatment, have been revisited by ProBiS. For the first time, the identification of conserved binding sites by local structural alignment … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 65 publications
0
12
0
2
Order By: Relevance
“…The conserved epitope paradigm has been a major focus for identification of vaccine targets that address the diversity of pathogens [35, 7174]. Sequences with extended conservation across different groups of a pathogen, such as influenza A virus (IAV) subtypes, have been proposed as universal vaccine candidates [72, 75].…”
Section: Discussionmentioning
confidence: 99%
“…The conserved epitope paradigm has been a major focus for identification of vaccine targets that address the diversity of pathogens [35, 7174]. Sequences with extended conservation across different groups of a pathogen, such as influenza A virus (IAV) subtypes, have been proposed as universal vaccine candidates [72, 75].…”
Section: Discussionmentioning
confidence: 99%
“…The antibody and the derived peptides bind to HA at the SA binding site, in particular to the 130-loop and the 190-helix, which belong to the antigenic sites A and B, respectively. This binding site is conserved among several HA serotypes providing a basis for a peptide with broader specificity [28].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, vaccination is the principal means to prevent IAV infection. The available vaccines are strain specific and are used to acquire neutralizing antibodies (13,14). However, gene reassortment and rapid antigenic mutation make the vaccines ineffective against newly emerged IAV strains.…”
mentioning
confidence: 99%